Pragmatic study designs may increase clinical trial participation among minority patients with multiples sclerosis (MS), according to researchers in the USA and UK.
Racial/ethnic minority groups are often underrepresented in randomized trials, the researchers noted. Pragmatic trials, such as the ongoing DELIVER-MS trial, have permissive entry requirements that may improve minority participation.